Heart and mind: (1) Relationship between cardiovascular and psychiatric conditions

Postgraduate Medical Journal

Volumn 80, Issue 950, 2004, Pages 683-689

  Shah, Saeed Ullah ^a,b   White, A ^b   White, S ^b   Littler, W A ^b  

^a YSBYTY GWYNEDD   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; CARDIOVASCULAR DISEASE; DEPRESSION; DRUG SAFETY; EMOTION; EVIDENCE BASED MEDICINE; HEART; HEART DISEASE; HUMAN; MEDLINE; MENTAL DISEASE; MOOD; PATHOPHYSIOLOGY; REVIEW;

EID: 10344225047     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2003.014662     Document Type: Review

References (125)

1. Rosenman RH, Brand RJ, Jenkins CD, et al. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 81/2 years. JAMA 1975;233:872-7.
2. Murray CJL, Lopez AD. The global burden of disease. Cambridge, MA: Harvard School of Public Health, 1996.
3. Howson CP, Reddy SK, Ryan TJ, et al. Control of cardiovascular diseases in developing countries. Washington, DC: National Academy Press, 1998.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Ed. Washington, DC: American Psychiatric Press, 1994.
5. Matthews KA, Gump BB. Chronic work stress and marital dissolution increase risk of post trial mortality in men from the Multiple Risk Factor Intervention Trial (MRFIT). Arch Intern Med 2002;162:309-15.
6. Miller TQ, Smith TW, Turner CW, et al. A meta-analytic review of research on hostility and physical health. Psychol Bull 1996;119:322-48.
7. Barefoot JC, Larsen L, von der Leith L, et al. Hostility, incidence of acute myocardial infarction and mortality in a sample of older Danish men and women. Am J Epidemiol 1995;142:477-84.
8. Kawachi I, Sparrow D, Spiro A, et al. A prospective study of anger and coronary heart disease: the Normative Aging Study. Circulation 1996;94:2090-5.
9. Shekelle RB, Gale M, Ostfield A, et al. Hostility, risk of coronary heart disease, and mortality. Psychosom Med 1983;45:109-14.
10. Gallacher JE, Yarnell JW, Sweetnam PM, et al. Anger and incident of heart disease in the Caerphilly study. Psychosom Med 1999;61:446-54.
11. Goodman M, Quigley J, Moran G, et al. Hostility predicts restenosis after percutaneous transluminal coronary angioplasty. Mayo Clin Proc 1996;71:729-34.
12. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285-94.
13. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-80.
14. Scheier MF, Matthews KA, Owens JF, et al. Optimism and rehospitalization after coronary artery bypass surgery. Arch Intern Med 1999;159:829-35.
15. Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scond 1994;377(suppl):77-82.
16. Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men. Arch Intern Med 1996;158:1422-6.
17. Hippisley-Cox J, Fielding K, Pringle M. Depression as a risk factor for ischemic heart disease in men: population based case-control study. BMJ 1998;316:1714-19.
18. Vogt T, Pope C, Mullooly J, et al. Mental health status as a predictor of morbidity and mortality. Am J Public Health 1994;84:227-31.
19. Wassertheil-Smoller S, Applegate WB, Berge K, et al. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch Intern Med 1996;56:553-61.
20. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: Impact on 6-month survival. JAMA 1993;270:1819-25.
21. Lespérance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58:99-110.
22. Carney RM, Rich MW, Tevelde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol 1987;60;1273-5.
23. McKhann GM, Borowicz LM, Goldsborough MA, et al. Depression and cognitive decline following coronary artery bypass grafting. Lancet 1996;349:1282-4.
24. Dunbar SB, Kimble LP, Jenkins LS, et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999;9:163-8.
25. Duru F, Buchi S, Klaghofer R. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart 2001;85:375-9.
26. Sullivan MD, LaCroix AZ, Baum C, et al. Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. Am J Med 1997;103:348-56.
27. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-33.
28. Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardiai infarction. Circulation 1995;91:999-1005.
29. Frasure-Smith N. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. Am J Cardiol 1991;67:121-7.
30. Musselman DL, Evans DL, Wemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-92.
31. Carney RM, Freedland KE, Eisen S, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14:88-90.
32. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ 1987;295:297-9.
33. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89:1992-7.
34. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation 1994;90:2225-9.
35. Kaprio J, Koskenvuo M, Rita H. Mortality after bereavement: a prospective study of 95,647 persons. Am J Public Health 1987;77:283-7.
36. Jiang W, Babyak M, Krantz DS, et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA 1996;21:1651-6.
37. Rozanski A, Bairey CN, Krantz DS. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005-12.
38. Krantz DS, Kop WJ, Santiago HT, et al. Mental stress as a trigger of myocardial ischemia and infarction. Cardiol Clin 1996;14:271-87.
39. Campbell S, Barry J, Rebecca GS, et al. Active transient myocardial ischemia during daily life in asymptomatic patients with positive exercise tests and coronary artery disease. Am J Cardiol 1986;57:1010-16.
40. Jiang W, Babyak M, Krantz DS, et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA 1996;21:1651-6.
41. Bosma H, Peter R, Siegrist J, et al. Two alternative job stress models and the risk of coronary heart disease. Am J Public Health 1998;88:68-74.
42. Karasek RA, Theorell TG, Schwartz J, et al. Job, psychological factors, and coronary heart disease: Swedish prospective findings and US prevalence findings using a new occupational inference method. Adv Cardiol 1982;29:62-87.
43. Alfredsson L, Spetz CL, Theorell T. Type of occupation and near-future hospitalization for myocardial infarction and some other diagnoses. Int J Epidemiol 1985;14:378-88.
44. Williams RB, Barefoot JC, Califf RM, et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 1992;267:520-4.
45. Johnson JV, Stewart W, Hall EM, et al. Long-term psychosocial work environment and cardiovascular mortality among Swedish males. Am J Public Health 1996;86:324-31.
46. Engel GL. Sudden and rapid death during psychological stress: folklore or folk wisdom? Ann Intern Med 1971;74:771-82.
47. Reich P, DeSilva RA, Lown B, et al. Acute psychological disturbance preceding life-threatening ventricular arrhythmias. JAMA 1981;246:233-5.
48. Myers A, Dewan HA. Circumstances attending 100 sudden deaths from coronary artery disease with coroner's necropsies. Br Heart J 1975;7:1133-43.
49. Rissanen V, Romo M, Siltanen P. Premonitory symptoms and stress factors preceding sudden death from ischemic heart disease. Acta Med Scand 1978;204:389-96.
50. Lown B, DeSilva RA. Roles of psychological stress and autonomic nervous system changes in provocation of ventricular premature complexes. Am J Cardiol 1978;41:979-85.
51. Follick MJ, Gorkin L, Capone RJ, et al. Psychological stress as a predictor of ventricular arrhythmias in a post-myocardial infarction population. Am Heart J 1988;116:32-6.
52. Kamarck T, Jennings JR. Biobehavioral factors in sudden cardiac death. Psychol Bull 1991;109:42-75.
53. Carney RM, Saunders RD, Freedland KE, et al. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562-4.
54. Spyer KM. Central nervous system control of the cardiovascular system. In: Bannister R, ed. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. Oxford, UK: Oxford University Press, 1988:56-79.
55. Sheilds RW. Functional anatomy of the autonomic nervous system. J Clin Neurophysiol 1993;10:2-13.
56. Suarez EC, Kuhn CM, Schanberg SM, et al. Neuroendocrine, cardiovascular, and emotional responses of hostile men: the role of interpersonal challenge. Psychosom Med 1998;60:78-88.
57. Wyatt RJ, Portnoy B, Kupfer DJ, et al. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971;24:65-70.
58. Roy A, Pickar D, DeJong J, et al. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine: relationship to hypothalamic-pituitary- adrenal axis function in depression. Arch Gen Psychiatry 1988;45:849-57.
59. Smagin GN, Heinrichs SC, Dunn AJ. The role of CRH in behavioral responses to stress. Peptides 2001;22:713-24.
60. Troxler RG, Sprague EA, Albanese RA, et al. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 1977;26:151-62.
61. Ross R, Harker L. Hyperlipidaemia and athero-sclerosis. Science 1976;193:1094-100.
62. Louis WJ, Doyle AE, Anavekar SN. Plasma nor-adrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin Soc 1975;48:239S-42.
63. Goldstern DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1983;5:86-99.
64. Anfossi G, Trovati M. Role of catecholamines in platelet function: pathophysical and clinical significance. Eur J Clin Invest 1996;26:353-70.
65. Kahn JP, Perumal AS, Gully RJ, et al. Correlation of type A behaviour with adrenergic receptor density: implications for coronary artery disease pathogenesis. Lancet 1987;ii:937-9.
66. Follick MJ, Ahern DK, Gorkin L, et al. Relation of psychosocial and stress reactivity variables to ventricular arrhythmias in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990;66:63-7.
67. Lown B, DeSilva RA. Roles of psychological stress and autonomic nervous system changes in provocation of ventricular premature complexes. Am J Cardiol 1978;41:979-85.
68. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18 month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
69. Corbalan R, Verrier R, Lown B. Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog. Am J Cardiol 1974;34:692-6.
70. Skinner JE, Lie JT, Entman ML. Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig. Circulation 1975;51:656-66.
71. Kleiger RE, Miller PJ, Bigger TJ, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
72. LaRovere MT, Specchia G, Mortana A, et al. Baroreflex sensifivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarcfion: a prospective study. Circulation 1988;78:816-24.
73. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982;66:874-80.
74. Miyawaki E, Salzman C. Autonomic nervous system tests in psychiatry: implications and potential uses of heart rate variability. Integrated Psychiatry 1991;7:21-8.
75. Carney RM, Saunders RD, Freeland KE, et al. Associafion of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562-4.
76. Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of poroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994;27:124-8.
77. Balogh S, Fitzpatrick DF, Hendricks SE, et al. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychoparmacol Bull 1993;29:201-6.
78. Meade TW, Ruddock V, Stirling Y, et al. Fibrinolytic activity, clotting factors, and long term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076-9.
79. Wilhelsmen L, Svardsudd K, Korsan-Bengesten K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
80. Brunner EJ, Davey Smith G, Marmot MG, et al. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 1996;347:1008-13.
81. Brunner EJ, Davey Smith G, Marmat MG, et al. When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. J Epidemiol Community Health 1999;53:757-64.
82. Musselmon DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
83. Markowitz JH, Mathews KA. Platelets and coronary heart disease:potential psychophysiologic mechanisms. Psychosom Med 1991;53:643-68.
84. Markowitz JH. Hostility is associated with increased platelet activity in coronary heart disease. Psychosom Med 1998;60:586-91.
85. Larrson PT, Hjemdahl P, Olsson G, et al. Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. Clin Sci 1989;76:369-76.
86. DeClerck F. Effects of serotonin on platelets and blood vessels. J Cardiovasc Pharmacol 1991;17(suppl 5):S1-S5.
87. Ashton JH, Ogletree ML, Michel IM, et al. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variation in dogs with severe coronary artery stenosis. Circulation 1987;76:952-9.
88. Biegon A, Weizman A, Karp L, et al. Serotonin 5-HT2 receptor binding on blood platelets: a peripheral marker for depression? Life Sci 1987;41:2485-92.
89. Biegon A, Grinspoon A, Blumenelt B, et al. Increased serotonin 5-HT2 receptor binding on blood platelets in suicidal men. Psychopharmacology 1990;100:165-7.
90. Pandy GN, Pandey PG, Janicak PG. Platelet serotonin-2 binding sites in depression and suicide. Biol Psychiatry 1990;28:215-22.
91. Osim EE, Wyllie JH. Evidence for loss of 5-hydroxytryptamine from circulating platelets. J Physiol (Lond) 1982;326:25P-6.
92. Owens MJ, Nemoerof CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994;40:288-95.
93. Ashton JH, Benedict CR, Fitzgerald C, et al. Serotonin as mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation 1986;73:572-8.
94. Musselman DL, Knight BT, Baron A, et al. Effects of paroxetine treatment on platelet reactivity in patients with major depression (abstract 86). Presented at the 37th annual meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 1998.
95. Laghirissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischaemic heart disease. Biol Psychiatry 1997;42:290-5.
96. Markowitz JH. Hostility is associated with increased platelet activity in coronary heart disease. Psychosam Med 1998;60:586-91.
97. Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963;27:929-34.
98. Young W, Gofman JW, Tandy R, et al. The quantitation of atherosclerosis. III. The extent of correlation of the degrees of atherosclerosis within and between the coronary and cerebral vascular beds. Am J Cardiol 1969;6:300-8.
99. Manuck SB, Kaplan JR, Adams MR, et al. Effects of stress and the sympathetic nervous system on coronary artery atherosclerosis in the cynomolgus macaque. Am Heart J 1988;116(1 pt 2):328-33.
100. Williams JK, Vita JA, Manuck SB, et al. Psychosocial factors impair vascular responses of coronary arteries. Circulation 1991;84:2146-53.
101. Kaplan JR, Manuck SB, Clarkson TB, et al. Social stress and atherosclerosis in normocholesterolemic monkeys. Science 1983;220:733-5.
102. Kaplan JR, Clarkson TB, Manuck SB. Pathogenesis of carotid bifurcation atherosclerosis in cynomolgus monkeys. Stroke 1984;15:994-1000.
103. Kaplan JR, Pettersson K, Manuck SB, et al. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. Circulation 1991;84(6 suppl):VI23-32.
104. Strawn WB, Bondjers G, Kaplan JR, et al. Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res 1991;68:1270-9.
105. Yeung AC, Vekshtein NI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551-6.
106. Kannel WB, Cobbs J. Left ventricular hypertrophy and mortality-results from the Framingham study. Cardiology 1992;81:291-8.
107. Mandawat MK, Wallbridge DR, Pringle SD, et al. Heart rate variability in left ventricular hypertrophy. Br Heart J 1995;73:139-44.
108. Kohara K, Hara N, Hiwada K. Left ventricular mass index negatively correlates with heart rate variability in essential hypertension. Am J Hypertens 1995;8:183-8.
109. Schnall PL, Pieper C, Schwartz JE, et al. The relationship between "job strain", workplace diastolic blood pressure and left ventricular mass index. Results of a case confrol study (published erratum appears in JAMA 1992;267:1209). JAMA 1990;263:1929-35.
110. Schnall PL, Pieper C, Schwartz JE, et al. The relationship between "job strain", workplace diastolic blood pressure and left ventricular mass index. Results of a case confrol study (published erratum appears in JAMA 1992;267:1209). JAMA 1990;263:1929-35.
111. Siegrist J, Peter R, Matz W, et al. the role of hypertension, left ventricular hypertrophy and psychosocial risks in cardiovascular disease; prospective evidence from blue collar men. Eur Heart J 1992;13(suppl D):89-95.
112. Markowitz JH, Raczynski JM, Lewis CE, et al. Lack of independent relationship between left ventricular mass and cardiovascular reactivity to physical and psychological stress in the Coronary Artery Risk Development in Young Adults (CARDIA) Study (see comments). Am J Hypertens 1996;9:915-23.
113. Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behaviour and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the Recurrent Coronary Prevention Project. Am Heart J 1986;112:653-65.
114. Frasure-Smith N, Prince R. The ischaemic heart disease life stress monitoring program: impact on mortality. Psychosom Med 1985;47:431-45.
115. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ 1996;313:1517-21.
116. Taylor CB, Miller NH, Smith PM, et al. The effect of a home-based, case-managed, multi-factorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease. Journal of Cardiopulmonary Rehabilitation 1997;17:157-62.
117. Frasure-Smith N, Lespeance F, Prince RH, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1997;350:473-9.
118. Shapiro PA, Lesperance F, Frasure-Smith N, et al. An open label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT trial). Am Heart J 1999;137:1100-6.
119. Glassman AH, O'Conner CM, Califf RM, et al. Sertalaine treatment of major depression in patients with acute MI or unstable angina (SADHART trial). JAMA 2002;288:701-14.
120. Ariyo AA, Haan M, Tangen CM, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000;102:1773-9.
121. Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch Intern Med 2000;160:1261-8.
122. Ford DE, Mead LA. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998;158:1422-6.
123. Sesso HD, Kawachi I, Vokonas PS. Depression and the risk of coronary heart disease in the Normative Aging Study. Am J Cardiol 1998;82:851-6.
124. Haines AAP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ 1987;295:297-9.
125. Kubzansky LD, Kawachi I, Spiro A, et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the normative aging study. Circulation 1997;95:818-24.